Sg Americas Securities, LLC Neoleukin Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$4.65 - $7.75 $103,881 - $173,135
-22,340 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$6.05 - $9.66 $135,157 - $215,804
22,340 New
22,340 $162,000
Q4 2020

Feb 04, 2021
SELL
$10.17 - $14.56 $1.31 Million - $1.87 Million
-128,627 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$9.68 - $17.01 $1.09 Million - $1.91 Million
112,451 Added 695.17%
128,627 $1.54 Million
Q2 2020

Jul 20, 2020
BUY
$9.95 - $17.05 $160,951 - $275,800
16,176 New
16,176 $269,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email